Posard Matthew L.
CIK 0001543792
Director
Filings
15
Latest May 7, 2026
Issuers covered
4
Showing
15 of 15
Page 1
Track record
5 of 5 open-market trades scored (100% price coverage). Returns are signed: a +10% move on a sale shows as -10% (insider was wrong).
| Horizon | Trades | Win rate | Avg | Median | Best | Worst |
|---|---|---|---|---|---|---|
| 30 days | 5 | 0% | -7.1% | -7.1% | -5.8% | -8.5% |
| 90 days | 5 | 0% | -12.0% | -9.1% | -3.8% | -19.3% |
| 180 days | 5 | 60% | -0.3% | +0.1% | +1.7% | -2.4% |
| 365 days | 5 | 0% | -12.5% | -14.2% | -7.9% | -16.3% |
Issuers
Companies where Posard Matthew L. has filed
| Ticker | Issuer | Filings | Last filed |
|---|---|---|---|
| HALO | Halozyme Therapeutics, Inc. | 7 | May 7, 2026 |
| NAUT | Nautilus Biotechnology, Inc. | 4 | Jun 25, 2025 |
| DMTK | Dermtech, Inc. | 2 | Jun 5, 2023 |
| TLIS | Talis Biomedical Corp | 2 | Jun 12, 2023 |
All filings
15 Form 4 / 4-A filings, newest first
| Filed | Top transaction | Shares | Price | Value | ||
|---|---|---|---|---|---|---|